JPMorgan Chase & Co. 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-07 1:24 pm Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 12,823,682 4.300% | -4,678,998 (-26.73%) | Filing |
| 2024-01-08 09:09 am Purchase | 2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 17,502,680 5.900% | 4,040,756 (+30.02%) | Filing |
| 2023-01-05 11:11 am Sale | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 13,461,924 4.700% | -1,876,753 (-12.24%) | Filing |
| 2022-01-19 12:37 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | JPMORGAN CHASE & CO JPM | 15,338,677 5.500% | 15,338,677 (New Position) | Filing |